Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT201009204780N1Phase 3Completed
Phase 3 trial of tranexamic acid in knee osteoarthritis (OA), sponsored by Vice Chancellor for Research of Mashhad University of Medical Sciences. Primary endpoint: Postoperative blood loss. Started Jan 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT201009204780N1.